Engineered lipid hybrid nanoparticles for targeted delivery of SH2 superbinder and breast cancer therapy
Abstract SH2 Superbinder (SH2S) is an engineered polypeptide tool derived from the SH2 domain. It exhibits significantly enhanced binding capacity for tyrosine-phosphorylated proteins to treat various cancers. However, its clinical application is limited by poor serum stability and insufficient tumo...
Guardat en:
| Autors principals: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2026-03-01
|
| Col·lecció: | Journal of Nanobiotechnology |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12951-026-04249-w |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
